Google Alert - lose weight

	lose weight As-it-happens update ⋅ December 12, 2025
	NEWS
	Want to lose weight this year? Keep these things in mind to stick to your resolution Times of India Expert shares how to make your weight loss strategy work. Every January, many people decide they want to improve their health and bring their weight ... Flag as irrelevant
	7 Best Dinner Foods for Losing Weight and Gaining Muscle - Eat This Not That Eat This Not That A dietitian reveals the top dinner foods that help you lose weight, stay full, and build muscle. Flag as irrelevant
	People Are Already Taking This Unapproved New Weight-Loss Drug | WIRED WIRED Unlike Shulgin or Baudelaire's experiments, retatrutide is not psychoactive. It's a weight-loss injectable, like semaglutide (marketed as Wegovy) or ... Flag as irrelevant
	Fitness coach explains why dieting is not the solution to sustainable weight loss Hindustan Times Are you thinking of going on a restrictive diet in order to lose weight? According to Raj Ganpath, that is not the solution to losing weight in ... Flag as irrelevant
	Taking a GLP-1? Dietitians Say These Fruits Are Perfect for Winter - EatingWell EatingWell GLP-1s curb appetite and slow digestion, supporting weight loss but complicating nutrient needs. · Enjoying winter fruits is an easy way to pack in ... Flag as irrelevant
	The Physiology Of the WEight Reduced State (POWERS) study: overview and study design Nature Some individuals regain most or all of their lost weight, while others are able to maintain their WL or even lose more weight. The weight-reduced ... Flag as irrelevant
	Lilly's three-pronged drug puts obesity field 'on notice' | BioPharma Dive BioPharma Dive Lilly's closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is "raising the bar" for future obesity ... Flag as irrelevant
	A better Ozempic? Eli Lilly's new obesity drug cut weight by 23%, study finds The Independent But weight loss wasn't the only major effect. Retratrutide also reduced arthritic knee pain by an average of 75.8 percent and significantly improved ... Flag as irrelevant
	Lilly reports dramatic weight loss in next-gen obesity-drug trial - MSN MSN Eli Lilly said its next generation weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in a late-stage trial. Flag as irrelevant
	Lilly's triple G agonist boasts 28.7% weight loss in Phase III trial Clinical Trials Arena Lilly is investigating the triple G agonist retatrutide in seven other Phase III trials, which are due to read out in 2026. Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback